
Organometallics
Organometallic compounds are those that contain bonds between carbon atoms and metals, usually transition metals such as magnesium, zinc, or platinum. These compounds exhibit a wide structural and chemical diversity, giving them high reactivity. They are mainly used in organic synthesis, catalysing reactions such as monomer polymerisation and carbon-carbon bond formation. Additionally, organometallic compounds have applications in the pharmaceutical industry, including the manufacture of anticancer drugs, as well as in industrial processes such as plastic and fuel production.
At CymitQuimica, we offer a wide range of organometallic compounds for research in organic chemistry, catalysis, and the synthesis of new materials.
Found 4400 products of "Organometallics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Amino-2,4,6-triiodoisophthalic Acid
CAS:Controlled Product<p>Impurity Iohexol EP Impurity K<br>Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.<br></p>Formula:C8H4I3NO4Color and Shape:NeatMolecular weight:558.842-Fluoro-3-methoxyphenylboronic acid
CAS:Controlled Product<p>Applications 2-Fluoro-3-methoxyphenylboronic acid<br></p>Formula:C7H8BFO3Color and Shape:NeatMolecular weight:169.9513-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid
CAS:<p>Applications 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent.<br>References Petersein, J. et al.: Am. J. Roentgenol., 165, 1167 (1995);<br></p>Formula:C13H22N4O5Color and Shape:White SolidMolecular weight:314.34(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Purity:98%Molecular weight:252.10000610351562Oxaliplatin
CAS:Controlled Product<p>Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H14N2O4PtColor and Shape:White To Off-WhiteMolecular weight:397.29Iohexol
CAS:Controlled Product<p>Applications Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H26I3N3O9Color and Shape:Off-WhiteMolecular weight:821.14Gadodiamide
CAS:Controlled Product<p>Applications Gadodiamide is an apoptosis inducing agent used in chondrocytes. It is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001);<br></p>Formula:C16H26GdN5O8Color and Shape:NeatMolecular weight:573.66Potassium Trichloroammineplatinate
CAS:Controlled Product<p>Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.<br>References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);<br></p>Formula:K·Cl3H3NPtColor and Shape:NeatMolecular weight:357.57Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Formula:C6H12N2O4PtColor and Shape:White To Off-WhiteMolecular weight:371.25DOTA
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Formula:C16H28N4O8Color and Shape:Light YellowMolecular weight:404.42N-Acetyl Cyclized Iodixanol
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications N-Acetyl Cyclized Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C35H43I5N6O15Color and Shape:NeatMolecular weight:1422.27Dihydroxy Oxaliplatin-Pt(IV)
CAS:Controlled Product<p>Applications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.<br>References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),<br></p>Formula:C8H16N2O6PtColor and Shape:White To Light YellowMolecular weight:431.30N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Impurity Iohexol USP Related Compound C<br>Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.<br>References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);<br></p>Formula:C14H19N3O8Color and Shape:White To Off-WhiteMolecular weight:357.32N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol
CAS:Controlled Product<p>Impurity Iohexol EP Impurity D<br>Applications N1-(3-(2,3-dihydroxypropoxy)-2-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Color and Shape:Off-WhiteMolecular weight:895.22Gadopentetic Acid
CAS:Controlled Product<p>Applications: Gadopentetic Acid is a magnetic resonance contrast agent being used to develop a new platform for the delivery of therapeutic and imaging agents simultaneously to the colon.<br>References Jin, M., et al.: Mol. Pharm, 13, 2457-2465 (2016)<br></p>Formula:C14H20GdN3O10Color and Shape:NeatMolecular weight:547.57Cyclic Iodixanol (90%)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C33H41I5N6O14Purity:90%Color and Shape:NeatMolecular weight:1380.23Oxaliplatin-d10
CAS:Controlled Product<p>Applications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H4D10N2O4PtColor and Shape:NeatMolecular weight:407.35Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate
CAS:Controlled Product<p>Impurity Oxaliplatin EP Impurity E<br>Stability Light Sensitive<br>Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.<br>References Gill, D.: Dev. Oncol., 17, 267 (1984);<br></p>Formula:C12H30N6O8Pt2Color and Shape:White To Light YellowMolecular weight:776.56

